» Articles » PMID: 12101443

Proliferative Vitreoretinopathy-developments in Adjunctive Treatment and Retinal Pathology

Overview
Journal Eye (Lond)
Specialty Ophthalmology
Date 2002 Jul 9
PMID 12101443
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Proliferative vitreoretinopathy (PVR) remains a difficult management problem despite advances in vitreoretinal surgery. There is still a significant incidence of PVR in rhegmatogenous retinal detachment and other forms of retinal disease. Surgery for PVR now has a high anatomical success rate although visual results are often disappointing. The use of adjunctive treatments to prevent cellular proliferation holds promise for the prevention of PVR or recurrences after surgery. Control of proliferation and strategies aimed at improving visual outcome are important areas of future research in PVR and other forms of retinal disease. Studies of the intraretinal and peri-retinal pathology of PVR have demonstrated characteristic changes which may have a significant influence on visual outcome and surgical management.

Citing Articles

An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy.

Hammer M, Ie A, Eibenberger K, Auffarth G, Xue K BMC Ophthalmol. 2025; 25(1):38.

PMID: 39844136 PMC: 11756122. DOI: 10.1186/s12886-024-03834-7.


Advancements in Therapeutic Approaches for Proliferative Vitreoretinopathy: A Comprehensive Review.

Dhawale K, Tidake P Cureus. 2024; 16(7):e65893.

PMID: 39219934 PMC: 11364703. DOI: 10.7759/cureus.65893.


The Effect of Anti-Autotaxin Aptamers on the Development of Proliferative Vitreoretinopathy.

Hanazaki H, Yokota H, Yamagami S, Nakamura Y, Nagaoka T Int J Mol Sci. 2023; 24(21).

PMID: 37958909 PMC: 10647324. DOI: 10.3390/ijms242115926.


The Application of MicroRNAs in Glaucoma Research: A Bibliometric and Visualized Analysis.

Zhang R, Tao Y, Huang J Int J Mol Sci. 2023; 24(20).

PMID: 37895056 PMC: 10607922. DOI: 10.3390/ijms242015377.


A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study.

Charteris D, Cro S, Casswell E, Tudor Edwards R, Ezeofor V, Anthony B Health Technol Assess. 2023; 27(12):1-50.

PMID: 37840322 PMC: 10591211. DOI: 10.3310/GNBJ1387.